Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000523023 | SCV000619304 | uncertain significance | not provided | 2022-01-03 | criteria provided, single submitter | clinical testing | Reported in a patient with combined hyperlipidemia (Gill et al., 2021); however, specific clinical information was not provided; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33303402) |
Robarts Research Institute, |
RCV000660688 | SCV000782856 | uncertain significance | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001837946 | SCV001418816 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000523023 | SCV001469339 | uncertain significance | not provided | 2020-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002329240 | SCV002634143 | likely benign | Cardiovascular phenotype | 2023-03-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mayo Clinic Laboratories, |
RCV000523023 | SCV004224851 | uncertain significance | not provided | 2022-04-28 | criteria provided, single submitter | clinical testing | BP4 |